Causal associations between atrial fibrillation and breast cancer: A bidirectional Mendelian randomization analysis
Cancer Medicine · 2024
DOI: 10.1002/cam4.7067 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von Zhaoting Gong und 3 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences & Pe…. Hauptthemen laut MEDLINE: Atrial Fibrillation, Breast Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Program during the Twelfth Five-year Plan Period, National Key Research and Development Program of China, CAMS Innovation Fund for Medical Sciences.
Abstract (Originalsprache)
Background
Previous observational studies indicated that atrial fibrillation may increase the risk of breast cancer. Following a breast cancer diagnosis, the chance of developing atrial fibrillation may increase as well. However, it is uncertain whether the link is causal or just due to confounding factors.
Objective
Using bidirectional Mendelian randomization (MR) analysis, we sought to assess the bidirectional causal relationship between atrial fibrillation and breast cancer from a genetic level.
Methods
Large genome‐wide association studies yielded summary‐level data for atrial fibrillation and breast cancer. The preliminary estimate was inverse variance weighted (IVW) under a random model. MR–Egger, weighted median, simple mode, weighted mode, and multivariable MR (adjusting body mass index, smoking, and alcohol drinking) were performed as sensitivity analyses.
Results
Genetically predicted atrial fibrillation presented no statistically significant association with overall breast cancer (odds ratio [OR] = 1.00; 95% confidence interval [CI]: 0.97–1.04; p = 0.79), estrogen receptor (ER) + (OR = 1.00; 95% CI: 0.96–1.03; p = 0.89) or ER− subtypes (OR = 1.00; 95% CI: 0.97–1.04; p = 0.89). Similarly, genetically predicted overall breast cancer (OR = 1.01; 95% CI: 0.98–1.04; p = 0.37), ER+ (OR = 1.02; 95% CI: 0.99–1.05; p = 0.16) or ER− (OR = 0.98; 95% CI: 0.93–1.02; p = 0.32) subtypes had no causal effect on atrial fibrillation. Sensitivity analyses yielded similar results. Individual single nucleotide polymorphism had little effect on the total estimate. We did not observe any evidence of horizontal pleiotropy.
Conclusions
Our bidirectional MR studies revealed that there may be no causal links between atrial fibrillation and breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
- Department of Cardiology, Xuanwu Hospital, Capital Medical University, Beijing, China.
ORCID-Profile: Zhaoting Gong, Mengjin Hu
Förderung
- National Science and Technology Program during the Twelfth Five-year Plan Period
- National Key Research and Development Program of China
- CAMS Innovation Fund for Medical Sciences
Zitieren
APA
Gong, Z., Hu, M., Yang, Y., & Yin, C. (2024). Causal associations between atrial fibrillation and breast cancer: A bidirectional Mendelian randomization analysis. Cancer Medicine. https://doi.org/10.1002/cam4.7067
Vancouver
Gong Z, Hu M, Yang Y, Yin C. Causal associations between atrial fibrillation and breast cancer: A bidirectional Mendelian randomization analysis. Cancer Medicine. 2024. doi:10.1002/cam4.7067
BibTeX
@article{Gong2024,
author = {Gong, Zhaoting and Hu, Mengjin and Yang, Yuejin and Yin, Chunlin},
title = {Causal associations between atrial fibrillation and breast cancer: A bidirectional Mendelian randomization analysis},
journal = {Cancer Medicine},
year = {2024},
doi = {10.1002/cam4.7067}
}
EUVIMED